Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, MD, FRCOG, Joachim W.

Editorial Board Member: / Bancalari, Eduardo / Greenough, Anne / Genc, Mehmet R. / Chervenak, Frank A. / Chappelle, Joseph / Bergmann, Renate L. / Bernardes, J.F. / Bevilacqua, G. / Blickstein, Isaac / Cabero Roura, Luis / Carbonell-Estrany, Xavier / Carrera, Jose M. / D`Addario, Vincenzo / D'Alton, MD, Mary E. / Dimitrou, G. / Grunebaum, Amos / Hentschel, Roland / Köpcke, W. / Kawabata, Ichiro / Keirse, Marc J.N.C. / Kurjak M.D., Asim / Lee, Ben H. / Levene, Malcolm / Lockwood, Charles J. / Marsal, Karel / Makatsariya, Alexander / Nishida, Hiroshi / Papp, Zoltán / Pejaver, Ranjan Kumar / Pooh, Ritsuko K. / Reiss, Irwin / Romero, Roberto / Saugstad, Ola D. / Schenker, Joseph G. / Sen, Cihat / Seri, Istvan / Vetter, Klaus / Winn, Hung N. / Young, Bruce K. / Zimmermann, Roland

9 Issues per year


IMPACT FACTOR 2016: 1.577
5-year IMPACT FACTOR: 1.705

CiteScore 2016: 1.49

SCImago Journal Rank (SJR) 2016: 0.602
Source Normalized Impact per Paper (SNIP) 2016: 0.832

Online
ISSN
1619-3997
See all formats and pricing
More options …
Volume 40, Issue 4 (Jun 2012)

Issues

Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis

Horst Buxmann
  • Corresponding author
  • Department of Neonatology, University Hospital, Johann Wolfgang Goethe University, Frankfurt/Main, Germany
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Otto M.v. Stackelberg
  • Department of Neonatology, University Hospital, Johann Wolfgang Goethe University, Frankfurt/Main, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rolf L. Schlößer
  • Department of Neonatology, University Hospital, Johann Wolfgang Goethe University, Frankfurt/Main, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Gisela Enders
  • Laboratory Prof. G. Enders and Partner and Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Markus Gonser / Matthias Meyer-Wittkopf / Klaus Hamprecht
  • Institute of Medical Virology and Epidemiology of Viral Disease, University Hospital, Eberhard-Karls University, Tuebingen, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Martin Enders
  • Laboratory Prof. G. Enders and Partner and Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2012-03-27 | DOI: https://doi.org/10.1515/jpm-2011-0257

Abstract

Aims: The aim of this study was to investigate the current prenatal “off-label use” of cytomegalovirus hyperimmunoglobulin (CMV-HIG) in the prevention and treatment of congenital CMV (cCMV) infection, including the long-term outcome of the children.

Methods: This retrospective observational study comprised mothers and their children, born between January 1, 2006, and October 30, 2010. Prenatal CMV-HIG was administered after diagnosis of primary CMV infection of the mother. Clinical and virological data were collected from maternal and pediatric medical and laboratory reports. Follow-up was 12–36 months after birth.

Results: Forty-two women and 43 children met the study criteria. In total, 40 mothers and six unborn infants received 115 doses of CMV-HIG. The treatment group (TG; CMV-DNA polymerase chain reaction-positive amniotic fluid) included four mothers; the multinomial group (MG; CMV-positive mother and unknown CMV status of fetus) included 38 mothers (39 infants). For the four unborn infants in TG, CMV-HIG was administered either intraumbilically or into the amniotic fluid; three of the four mothers received intravenous CMV-HIG. Three children in TG remained CMV-positive and were asymptomatic at birth and during follow-up. One infant in TG had symptomatic cCMV infection in utero, at birth, and during follow-up. In MG, 37 of 38 women received intravenous CMV-HIG and two of 39 infants received CMV-HIG in utero. In total, 9 (23.1%) of 39 children in MG were positive for cCMV (including a terminated pregnancy). All eight instances of cCMV infection at birth in MG were asymptomatic at birth and during follow-up. The fetus from the terminated pregnancy showed no sonographic symptoms of cCMV infection. No severe side effect occurred in 115 CMV-HIG applications.

Conclusion: CMV-HIG was well tolerated. Compared with published untreated mother-child pairs, we observed a trend toward a smaller risk for intrauterine CMV transmission following CMV-HIG application. Signs of prenatal cCMV disease were not reversed after CMV-HIG.

Keywords: CMV hyperimmunoglobulin; congenital cytomegalovirus disease; congenital cytomegalovirus infection; cytomegalovirus; cytomegalovirus transmission; pregnancy; prevention; primary cytomegalovirus infection; treatment

About the article

Corresponding author: Dr. med. Horst Buxmann University Hospital Johann Wolfgang Goethe University Department of Neonatology Theodor Stern Kai 7 D-60590 Frankfurt am Main Germany Tel.: +49 69 6301 5524 Fax: +49 69 6301 4757


Received: 2011-10-12

Revised: 2011-12-18

Accepted: 2012-02-07

Published Online: 2012-03-27

Published in Print: 2012-06-01


Citation Information: , ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/jpm-2011-0257.

Export Citation

©2012 by Walter de Gruyter Berlin Boston. This content is open access.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Uwe Fiebig, Angela Holzer, Daniel Ivanusic, Elena Plotzki, Hartmut Hengel, Frank Neipel, and Joachim Denner
Viruses, 2017, Volume 9, Number 11, Page 317
[3]
Daniel Blázquez-Gamero, Alberto Galindo Izquierdo, Teresa Del Rosal, Fernando Baquero-Artigao, Nuria Izquierdo Méndez, María Soriano-Ramos, Pablo Rojo Conejo, María Isabel González-Tomé, Antonio García-Burguillo, Noelia Pérez Pérez, Virginia Sánchez, Jose Tomás Ramos-Amador, and Maria De la Calle
The Journal of Maternal-Fetal & Neonatal Medicine, 2017, Page 1
[4]
Jessica L. Coleman and Russell W. Steele
Clinical Pediatrics, 2017, Page 000992281772440
[5]
Karl Oliver Kagan and Klaus Hamprecht
Archives of Gynecology and Obstetrics, 2017, Volume 296, Number 1, Page 15
[6]
New England Journal of Medicine, 2014, Volume 370, Number 26, Page 2543
[7]
William D Rawlinson, Suresh B Boppana, Karen B Fowler, David W Kimberlin, Tiziana Lazzarotto, Sophie Alain, Kate Daly, Sara Doutré, Laura Gibson, Michelle L Giles, Janelle Greenlee, Stuart T Hamilton, Gail J Harrison, Lisa Hui, Cheryl A Jones, Pamela Palasanthiran, Mark R Schleiss, Antonia W Shand, and Wendy J van Zuylen
The Lancet Infectious Diseases, 2017, Volume 17, Number 6, Page e177
[8]
Daniele Lilleri and Giuseppe Gerna
Reviews in Medical Virology, 2017, Volume 27, Number 2, Page e1921
[9]
Jessica J. Falk, Martina Winkelmann, Hubert Schrezenmeier, Dagmar Stöhr, Christian Sinzger, and Ramin Lotfi
Transfusion, 2017, Volume 57, Number 2, Page 412
[10]
Zin W. Naing, Gillian M. Scott, Antonia Shand, Stuart T. Hamilton, Wendy J. van Zuylen, James Basha, Beverly Hall, Maria E. Craig, and William D. Rawlinson
Australian and New Zealand Journal of Obstetrics and Gynaecology, 2016, Volume 56, Number 1, Page 9
[11]
Alexia Willame, Geraldine Blanchard-Rohner, Christophe Combescure, Olivier Irion, Klara Posfay-Barbe, and Begoña Martinez de Tejada
International Journal of Environmental Research and Public Health, 2015, Volume 12, Number 12, Page 15285
[12]
S. M. Miescher, T. M. Huber, M. Kühne, P. Lieby, D. R. Snydman, J. L. Vensak, and M. Berger
Vox Sanguinis, 2015, Volume 109, Number 1, Page 71
[13]
Stuart T. Hamilton, Wendy van Zuylen, Antonia Shand, Gillian M. Scott, Zin Naing, Beverley Hall, Maria E. Craig, and William D. Rawlinson
Reviews in Medical Virology, 2014, Volume 24, Number 6, Page 420
[14]
Martin Zydek, Matthew Petitt, June Fang-Hoover, Barbara Adler, Lawrence Kauvar, Lenore Pereira, and Takako Tabata
Viruses, 2014, Volume 6, Number 3, Page 1346
[15]
Tong-Ming Fu, Zhiqiang An, and Dai Wang
Vaccine, 2014, Volume 32, Number 22, Page 2525
[16]
Cariad M. Evans, Goura Kudesia, and Mike McKendrick
International Journal of Antimicrobial Agents, 2013, Volume 42, Number 2, Page 119
[17]
Elizabeth C. Swanson and Mark R. Schleiss
Pediatric Clinics of North America, 2013, Volume 60, Number 2, Page 335
[18]
C. Evans, A. Brooks, D. Anumba, and M. Raza
Journal of Clinical Virology, 2013, Volume 57, Number 2, Page 95

Comments (0)

Please log in or register to comment.
Log in